Cargando…
A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine
Autores principales: | Yamada, Shunsuke, Yamada, Kanako, Nishida, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593167/ https://www.ncbi.nlm.nih.gov/pubmed/35871588 http://dx.doi.org/10.2169/internalmedicine.0319-22 |
Ejemplares similares
-
New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine
por: Osada, Atsumu, et al.
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Guillain Barre Syndrome: case report
Publicado: (2021) -
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)